Literature DB >> 16214069

Hyperalgesia and allodynia: peripheral mechanisms.

Anne Coutaux1, Frédéric Adam, Jean-Claude Willer, Daniel Le Bars.   

Abstract

Nociceptive signals are generated by peripheral sensory organs called nociceptors, which are endings of small-diameter nerve fibers responsive to the tissue environment. The myriad chemical mediators capable of activating, sensitizing, or arousing nociceptors include kinins, proinflammatory and anti-inflammatory cytokines, prostanoids, lipooxygenases, the "central immune response mediator" NF-kappaB, neurotrophins and other growth factors, neuropeptides, nitric oxide, histamine, serotonin, proteases, excitatory amino acids, adrenergic amines, and opioids. These mediators may act in combination or at a given time in the inflammatory process, producing subtle changes that result in hyperalgesia or allodynia. We will review the most extensively studied molecular and cellular mechanisms underlying these two clinical abnormalities. The role of the peripheral nervous system in progression of inflammatory joint disease to chronicity is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214069     DOI: 10.1016/j.jbspin.2004.01.010

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  48 in total

1.  Involvement of substance P, osteopontin and satellite glial cells on photobiomodulation-induced antinociceptive effect in an experimental model of dentin hypersensitivity.

Authors:  Victhor Teixeira de Oliveira; João Ignácio Ferrara-Jr; Heloísa Alonso Matielo; Adilson da Silva Alves; Luiz Roberto Britto; Ana Cecilia Corrêa Aranha; Camila Squarzoni Dale
Journal:  Lasers Med Sci       Date:  2021-01-15       Impact factor: 3.161

Review 2.  Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

Authors:  Xiao-Min Wang; Tanya J Lehky; Joanna M Brell; Susan G Dorsey
Journal:  Cytokine       Date:  2012-04-24       Impact factor: 3.861

Review 3.  Kinesins: Motor Proteins as Novel Target for the Treatment of Chronic Pain.

Authors:  P A Shantanu; Dilip Sharma; Monika Sharma; Shivani Vaidya; Kuhu Sharma; Kiran Kalia; Yuan-Xiang Tao; Amit Shard; Vinod Tiwari
Journal:  Mol Neurobiol       Date:  2018-09-13       Impact factor: 5.590

4.  Antihypernociceptive activity of anethole in experimental inflammatory pain.

Authors:  Alessandra M V Ritter; Talita P Domiciano; Waldiceu A Verri; Ana Carla Zarpelon; Lorena G da Silva; Carmem P Barbosa; Maria Raquel M Natali; Roberto K N Cuman; Ciomar A Bersani-Amado
Journal:  Inflammopharmacology       Date:  2012-10-09       Impact factor: 4.473

5.  [Transcription of protein arginine N-methyltransferase genes in mouse dorsal root ganglia following peripheral nerve injury].

Authors:  Hua-Li Xu; Shi-Yuan Xu; Kai Mo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

6.  Molecular control limiting sensitivity of sweet taste neurons in Drosophila.

Authors:  Hsueh-Ling Chen; Ulrich Stern; Chung-Hui Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-16       Impact factor: 11.205

7.  Immediate effects of a thoracic spine thrust manipulation on the autonomic nervous system: a randomized clinical trial.

Authors:  Rob Sillevis; Joshua Cleland; Madeleine Hellman; Kristina Beekhuizen
Journal:  J Man Manip Ther       Date:  2010-12

8.  Preventive and therapeutic effects of a beta adrenoreceptor agonist, dobutamine, in carrageenan-induced inflammatory nociception in rats.

Authors:  Tufan Mert; Berin Tugtag; Metin Kilinc; Elif Sahin; Hafize Oksuz; Yasemin Gunes
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

9.  Acid-sensing ion channel 3 expression in mouse knee joint afferents and effects of carrageenan-induced arthritis.

Authors:  Masahiko Ikeuchi; Sandra J Kolker; Kathleen A Sluka
Journal:  J Pain       Date:  2009-01-29       Impact factor: 5.820

10.  Post heat shock tolerance: a neuroimmunological anti-inflammatory phenomenon.

Authors:  Shahram Shahabi; Zuhair M Hassan; Nima Hosseini Jazani
Journal:  J Inflamm (Lond)       Date:  2009-03-27       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.